1. All advertisements are subject to review by the Arthritis Foundation and its Advertising Standards Committee. Acceptance of an advertisement in Arthritis Today does not in any way imply Arthritis Foundation endorsement of a product or service. Neither the Foundation's name nor logo may be used in any ad, except in the case of companies that have a contractual agreement with the Foundation. At no time should Arthritis Today's name, logo, or editorial staff be used in any way that suggest editorial endorsements of any advertiser. Follow-up material mailed to readers as a result of an advertisement in Arthritis Today cannot refer to the publication or to the Arthritis Foundation as the source of the request. Using such implied endorsement will be cause for termination of the advertising.

2. The Arthritis Foundation reserves the right to refuse or to cancel any advertisements without giving cause, including those from a previous advertiser. Each advertisement submitted by a company is subject to individual review.

3. Advertisements must contain no misleading statements or information, and must be free of any false claims. The Arthritis Foundation interprets "misleading" to include a general impression, which may be presented, as well as a specific statement. Before the advertisement is accepted, advertisers must be able to substantiate any claims made regarding the therapeutic effectiveness of the product in treating arthritis.

4. All advertised products must meet applicable guidelines of the Food and Drug Administration (FDA), federal and state governments and private associations such as the Council of Better Business Bureaus. Advertisers must be willing to supply an actual sample of the advertised product for review on request.

5. Advertisers of any product for personal consumption (e.g. - medications, vitamins, lotions, food) must be willing to supply a complete listing of ingredients as they appear on the product label, when requested. Advertisers of any product (e.g. - self-help aids, devices) must be willing to supply complete product specifications on request.

6. Advertisements for prescription drugs will be accepted on a case-by-case basis, provided they meet all FDA requirements.

7. Complete ad copy and proposed graphics must be submitted for review. No rough layouts or tissues will be acceptable - only final comprehensive layouts and color proofs are required for four-color ads.

8. Headline and body copy typefaces or editorial style ads must be clearly distinguishable from the basic editorial typefaces of the magazine. The word "PAID ADVERTISEMENT" must be printed at the top of the editorial-type ads. The word "ADVERTORIAL" should not be used.